Funded Tech Companies
Avenzo Therapeutics
Operating out of San Diego, Avenzo Therapeutics has funding from SR One Capital Management, Lilly Asia Ventures and OrbiMed.
Company Overview
Company Name
Avenzo Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
12707 High Bluff Drive 200
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Avenzo Therapeutics is a clinical-stage biotechnology company co-founded in 2022 by Dr. Athena Countouriotis and Dr. Mohammad Hirmand. The company is building and advancing a pipeline of potential best-in-class oncology therapies that target cell cycle control to prevent the aberrant cell proliferation that drives many cancers.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/22/2025
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Athena Countouriotis
Chief Financial Officer
Paolo Tombesi
Chief Medical Officer
Mohammad Hirmand
Vice President
Melissa Fitzgerald
Vice President
Ming Lu
Vice President
Minal Mehta
VP - Bus. Development
Scott Lipman
VP - General Counsel
Brian Sun
VP - Marketing
Carla Taub
VP - Operations
Melissa Holmes
VP - Regulatory Affairs
Naresh Nayyar
Company Investors
- SR One Capital Management
- Lilly Asia Ventures
- OrbiMed
- Sands Capital Management
- Delos Capital
- INCE Capital
- New Enterprise Associates
- Longwood Fund
- Foresite Capital
- Quan Capital
- Deep Track Capital
- TF Capital
- Sofinnova Ventures
- Surveyor Capital
- Sofinnova Partners
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs